OverviewChartTechnicalNewsTraderScreen

PREVECEUTICAL MED./  CA74141E1043  /

Frankfurt
10/4/2024  8:04:44 AM Chg. 0.0000 Volume Bid3:30:10 PM Ask3:30:10 PM High Low
0.0100EUR 0.00% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 0.0100 0.0100
Newsfile Corp 2/7/2023 PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development
Newsfile Corp 1/12/2023 PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
Newsfile Corp 7/7/2021 PreveCeutical Files International Patent Application for its Dynorphin Peptides
Newsfile Corp 3/15/2021 PreveCeutical Appoints Founding Director of RAS Life Science Solutions Aditya Bahl as Advisor
Newsfile Corp 2/23/2021 Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical
Newsfile Corp 2/2/2021 PreveCeutical Announces Completion of Pain Management Peptides Program
Newsfile Corp 1/5/2021 PreveCeutical files Provisional Patent Application for its BSV Peptide
Newsfile Corp 11/25/2020 Successful Completion of the COVID-19 Sol-Gel Formulation Development
Newsfile Corp 11/23/2020 PreveCeutical Files Provisional Patent Application for its COVID-19 Formulation
Newsfile Corp 11/10/2020 PreveCeutical Provides Update on Its COVID-19 Cannabinoid Sol-Gel Program
Newsfile Corp 10/1/2020 Veteran Johnson & Johnson Executive Dr. Ajit Shetty Joins PreveCeutical
Newsfile Corp 9/8/2020 PreveCeutical Provides Lead Pain Management Peptides Update
Newsfile Corp 9/2/2020 PreveCeutical Announces Lead Pain Management Peptides Identified for Preclinical Evaluation
Newsfile Corp 8/31/2020 PreveCeutical Files an Application for a Provisional Patent for Sol-gel Cannabinoids
Newsfile Corp 8/17/2020 PreveCeutical Receives AU$1,227,902 Research & Development Tax Incentive Cash Refund
Newsfile Corp 7/21/2020 PreveCeutical Approaches Completion of Non-Addictive Analgesic Program
Newsfile Corp 7/15/2020 PreveCeutical Announces Advance in the Formulation and Biological Delivery of Therapy for Diabetes a...
Newsfile Corp 7/13/2020 PreveCeutical Confirms Receipt of CBD For Sol-Gel
Newsfile Corp 7/6/2020 PreveCeutical Announces Stability Data from CBD Sol-gel Product Development Program
Newsfile Corp 6/29/2020 PreveCeutical Announces Promising 3D Liver Tissue Testing of Potential Therapy for Diabetes and Obes...
Newsfile Corp 6/22/2020 PreveCeutical Executes Agreement for Development of CBD Sol-Gel Nasal Spray Formulation as a Potenti...
Newsfile Corp 6/17/2020 PreveCeutical Announces Sol-Gel Chemistry Fingerprinting SOPs
Newsfile Corp 6/15/2020 PreveCeutical Announces Further Successful Results from The Sol-Gel Program Final Report
Newsfile Corp 6/3/2020 PreveCeutical Announces Successful Completion of its Sol-gel Program
Newsfile Corp 6/1/2020 PreveCeutical Applies for Viral Prevention Program Funding